Overview
Diabetes is one of the four major types of noncomunicable diseases (NCDs) that make the largest contribution to morbidity and mortality worldwide. The prevalence of diabetes increasing in Bangladesh. In 2021, the International Diabetes Federation estimated 13.1 milion people were living with diabetes in Bangladesh and projected to be almost doubled by 2025.While managing diabetes, one of the prime concerns of healthcare profesionals remains as how to reduce HbA1c eficiently without trigering any other comorbidities.
Key Information
SGLT2 (Sodium-glucose Cotransporter-2) Inhibitors, in that context, plays a pivotal role in the diabetes treatment regime. Synovia Pharma brought a breakthrough new and inovative solutions to cater to the unmet neds of Bangladeshi patients, says a pres release.Eminent physician Profesor A K Azad Khan, National Profesor and President of the Diabetes Asociation of Bangladesh graced the launching event as the Chief Guest.
Summary
Profesor Md Faruque Pathan, Profesor of Endocrinology, BIRDEM General Hospital chaired the programe where Profesor S M Ashrafuzaman - Profesor and President of Bangladesh Endocrine Society was present as the Special Guest.Prof Indrajit Prasad, Head of Endocrinology, Dhaka Medical Colege Hospital presented 'Diabetes Management Focusing on CVD Outcome' and Prof Shamim Ahmed, National Institute of Kidney Diseases & Urology (NIKDU) presented 'Diabetes Management Focusing on Renal Protection.'রাজশাহীর ৯ ভোটকেন্দ্রের ১৮ বুথে জেলা পরিষদ নির্বাচন চলছে।source